Blooming Pharma Industry with Transdermal Drug Delivery System

The human skin is a readily accessible surface for drug delivery.It is one of the most readily accessible organs of the human body. The potential of using the intact skin as the port of drug administration to the human body has been recognized for several decades, but skin is a very difficult barrier to the ingress of materials allowing only small quantities of a drug to penetrate over a period of time. During the past decade, the number of drugs formulated in the patches has hardly increased, and there has been little change in the composition of the patch systems. Modifications have been mostly limited to refinements of the materials used. The present article reviews the selection of drug candidates suitable to be formulated as Transdermal system and the methods of evaluation are also stated. © 2011 IGJPS. All rights reserved.

[1]  E. Neumann,et al.  Stochastic model for electric field-induced membrane pores. Electroporation. , 1984, Biophysical chemistry.

[2]  F. Puisieux,et al.  Formulation study of a transdermal delivery system of primaquine , 1996 .

[3]  Ritesh Kumar,et al.  Modified Transdermal Technologies: Breaking the Barriers of Drug Permeation via the Skin , 2007 .

[4]  M. Azuma,et al.  Relationship between the transference of a drug from a transdermal patch and the physicochemical properties. , 1992, Chemical & pharmaceutical bulletin.

[5]  S. Chung,et al.  Future drug delivery research in South Korea. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[6]  P. Vavia,et al.  Formulation Optimization and Stability Study of Transdermal Therapeutic System of Nicorandil , 2002, Pharmaceutical development and technology.

[7]  D. Hsieh,et al.  Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations. , 1990, Medical device technology.

[8]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[9]  I. Sugár.  Stochastic Model of Electric Field-Induced Membrane Pores , 1989 .

[10]  M. Okumura,et al.  Re: Topical application of glibenclamide lowers blood glucose levels in rats. , 1988, Diabetes research and clinical practice.

[11]  N. G. Popovich,et al.  Pharmaceutical Dosage Forms and Drug Delivery Systems , 1990 .

[12]  Russell O. Potts,et al.  Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans , 1995 .

[13]  J. Hadgraft,et al.  Microviscosity and drug release from topical gel formulations , 1986, Pharmaceutical Research.

[14]  J. Heller,et al.  Controlled drug release by polymer dissolution. II: Enzyme-mediated delivery device. , 1979, Journal of pharmaceutical sciences.

[15]  N. Udupa,et al.  Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation , 2006 .

[16]  Majella E Lane,et al.  Skin penetration enhancers. , 2013, International journal of pharmaceutics.

[17]  P. Verma,et al.  Transdermal Delivery of Propranolol Using Mixed Grades of Eudragit: Design and in Vitro and In Vivo Evaluation , 2000, Drug development and industrial pharmacy.

[18]  K. Pundarikakshudu,et al.  Studies in formulation and pharmacotechnical evaluation of controlled release transdermal delivery system of bupropion , 2008, AAPS PharmSciTech.

[19]  B. Mishra,et al.  Delivery of macromolecules through skin , 2004 .

[20]  R. R. Crawford,et al.  Effect of plasticizers on some physical properties of cellulose acetate phthalate films. , 1971, Journal of pharmaceutical sciences.

[21]  J. Hadžiabdić,et al.  [Transdermal drug delivery systems]. , 2004, Medicinski arhiv.

[22]  Sang‐Chul Shin,et al.  Enhancing Effects of Fatty Acids on Piroxicam Permeation Through Rat Skins , 2000, Drug development and industrial pharmacy.

[23]  F. Ahmad,et al.  Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics , 2007, AAPS PharmSciTech.

[24]  Md. Selim Reza,et al.  Controlled Release of Naproxen Sodium from Eudragit RS 100 Transdermal Film , 2007 .

[25]  Adrian C. Williams,et al.  Penetration enhancers. , 2004, Advanced drug delivery reviews.

[26]  P. Diwan,et al.  Permeability studies of cellulose acetate free films for transdermal use: influence of plasticizers. , 1997, Pharmaceutica acta Helvetiae.

[27]  P. Minghetti,et al.  Dermal patches for the controlled release of miconazole: influence of the drug concentration on the technological characteristics. , 1999, Drug development and industrial pharmacy.

[28]  M. Guyot,et al.  Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol. , 2000, International journal of pharmaceutics.

[29]  L. Bromberg.  Crosslinked poly(ethylene glycol) networks as reservoirs for protein delivery , 1996 .

[30]  K. Cal,et al.  Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. , 2000, International journal of pharmaceutics.

[31]  K. Tripathi,et al.  Effect of Penetration Enhancers on the in Vitro Transport of Ephedrine Through Rat Skin and Human Epidermis from Matrix Based Transdermal Formulations , 1993 .

[32]  W. Pfister,et al.  Pressure-sensitive adhesives for transdermal drug delivery systems. , 1999, Pharmaceutical science & technology today.

[33]  Pharmaceutical Press,et al.  Handbook of Pharmaceutical Excipients , 2012 .

[34]  Y. Vishnu,et al.  Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. , 2007, Current drug delivery.

[35]  Xiao Yan-Yu,et al.  Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. , 2006, International journal of pharmaceutics.

[36]  S. W. Kim,et al.  One-way membrane for transdermal drug delivery systems. II. System optimization , 1991 .

[37]  L. Allen.  Pharmaceutical Dosage Forms and Drug Delivery Systems, Fifth Edition , 1990 .

[38]  Takashi Yamamoto,et al.  Topical application of the hypoglycemic agent glibenclamide and changes in blood glucose, plasma insulin (IRI) levels and plasma concentration of glibenclamide in normal rats. , 1990, Diabetes Research and Clinical Practice.

[39]  A. Prochazka.  New developments in smoking cessation. , 2000, Chest.

[40]  T. Ghosh,et al.  Transdermal and Topical Drug Delivery Systems , 2004, Theory and Practice of Contemporary Pharmaceutics.

[41]  许旱峤,et al.  Kirk-Othmer Encyclopedia of Chemical Technology数据库介绍及实例 , 2007 .

[42]  J. Wiechers.  Model systems in iontophoresis--transport efficacy. , 1992 .

[43]  U. Banakar,et al.  Proliposome-Based Transdermal Delivery of Levonorgestrel , 1997, Journal of biomaterials applications.